A drug has to grab something
Pharmacodynamics is the half of pharmacology that asks: what does the drug do to the body? The other half, pharmacokinetics, asks the reverse — what does the body do to the drug. Today we stay with the first question, and it has a surprisingly simple starting point. A drug can only act by physically touching a molecule in your body. That target molecule is usually a receptor, and a receptor is best pictured as a tiny switch built out of protein.
Anything that binds a receptor is called a ligand — the word just means "a thing that binds." Your own body makes ligands: hormones, neurotransmitters, and other signaling molecules are the receptor's natural partners, collectively the endogenous ligands. Many drugs work by imitating or blocking these natural messengers at the very same drug target.
Where the key fits: the binding site
The key does not touch the whole lock — only a small pocket on the receptor's surface called the binding site. Its shape and chemistry are why one molecule fits and another bounces off. This shape-matching is the source of selectivity: it explains why an asthma inhaler can calm the lungs without stopping the heart, even though both organs carry related receptors.
When a ligand settles into the binding site of a receptor, two completely separate questions arise. First: how tightly does it stick? Second: once stuck, does it actually do anything? Holding on and turning the switch are different talents, and the next guide is built entirely around that split.
Agonists turn the switch on
A ligand that binds and flips the switch on — producing the same kind of response the body's own messenger would — is an agonist. Adrenaline is a natural agonist; the salbutamol in an asthma inhaler is a drug agonist that mimics it at lung receptors. Agonists are how a pill makes something *happen*. A drug's mechanism of action is, very often, simply the answer to "which receptor does it agonize, and where?"